nodes	percent_of_prediction	percent_of_DWPC	metapath
Secobarbital—CYP1A2—Imiquimod—skin cancer	0.209	0.234	CbGbCtD
Secobarbital—CYP2C8—Vismodegib—skin cancer	0.187	0.21	CbGbCtD
Secobarbital—CYP2C9—Vismodegib—skin cancer	0.131	0.146	CbGbCtD
Secobarbital—CYP1A2—Vemurafenib—skin cancer	0.115	0.128	CbGbCtD
Secobarbital—CYP1A2—Dacarbazine—skin cancer	0.0879	0.0983	CbGbCtD
Secobarbital—CYP2C8—Fluorouracil—skin cancer	0.0665	0.0744	CbGbCtD
Secobarbital—CYP1A2—Fluorouracil—skin cancer	0.0515	0.0576	CbGbCtD
Secobarbital—CYP2C9—Fluorouracil—skin cancer	0.0464	0.0519	CbGbCtD
Secobarbital—GRIK2—nerve—skin cancer	0.00312	0.121	CbGeAlD
Secobarbital—CHRNA7—skin epidermis—skin cancer	0.00298	0.116	CbGeAlD
Secobarbital—CHRNA4—nerve—skin cancer	0.0025	0.0971	CbGeAlD
Secobarbital—Dermatitis exfoliative—Imiquimod—skin cancer	0.00245	0.0306	CcSEcCtD
Secobarbital—Liver injury—Temozolomide—skin cancer	0.00226	0.0283	CcSEcCtD
Secobarbital—Respiratory failure—Temozolomide—skin cancer	0.00194	0.0242	CcSEcCtD
Secobarbital—Constipation—Vismodegib—skin cancer	0.00184	0.023	CcSEcCtD
Secobarbital—Depressed level of consciousness—Temozolomide—skin cancer	0.00184	0.023	CcSEcCtD
Secobarbital—GABRA3—neck—skin cancer	0.00169	0.0656	CbGeAlD
Secobarbital—Mental disability—Temozolomide—skin cancer	0.00165	0.0207	CcSEcCtD
Secobarbital—Dermatitis exfoliative—Temozolomide—skin cancer	0.00147	0.0183	CcSEcCtD
Secobarbital—CHRNA7—neck—skin cancer	0.00143	0.0553	CbGeAlD
Secobarbital—Vomiting—Vismodegib—skin cancer	0.00137	0.0171	CcSEcCtD
Secobarbital—Rash—Vismodegib—skin cancer	0.00136	0.017	CcSEcCtD
Secobarbital—Dermatitis—Vismodegib—skin cancer	0.00136	0.0169	CcSEcCtD
Secobarbital—Ataxia—Temozolomide—skin cancer	0.0013	0.0162	CcSEcCtD
Secobarbital—Respiratory failure—Docetaxel—skin cancer	0.00129	0.0161	CcSEcCtD
Secobarbital—Nausea—Vismodegib—skin cancer	0.00128	0.016	CcSEcCtD
Secobarbital—Agitation—Imiquimod—skin cancer	0.00128	0.016	CcSEcCtD
Secobarbital—Angioedema—Imiquimod—skin cancer	0.00127	0.0159	CcSEcCtD
Secobarbital—Hepatocellular injury—Docetaxel—skin cancer	0.00127	0.0158	CcSEcCtD
Secobarbital—Injection site reaction—Docetaxel—skin cancer	0.00126	0.0157	CcSEcCtD
Secobarbital—Syncope—Imiquimod—skin cancer	0.00125	0.0156	CcSEcCtD
Secobarbital—Hypotension—Vemurafenib—skin cancer	0.00124	0.0155	CcSEcCtD
Secobarbital—Loss of consciousness—Imiquimod—skin cancer	0.00122	0.0153	CcSEcCtD
Secobarbital—Ataxia—Fluorouracil—skin cancer	0.0012	0.015	CcSEcCtD
Secobarbital—Anxiety—Imiquimod—skin cancer	0.00118	0.0147	CcSEcCtD
Secobarbital—Constipation—Vemurafenib—skin cancer	0.00114	0.0142	CcSEcCtD
Secobarbital—Shock—Imiquimod—skin cancer	0.00112	0.0139	CcSEcCtD
Secobarbital—Body temperature increased—Vemurafenib—skin cancer	0.00105	0.0131	CcSEcCtD
Secobarbital—Somnolence—Imiquimod—skin cancer	0.00101	0.0126	CcSEcCtD
Secobarbital—Hypersensitivity—Vemurafenib—skin cancer	0.00098	0.0122	CcSEcCtD
Secobarbital—GABRA4—mammalian vulva—skin cancer	0.000972	0.0377	CbGeAlD
Secobarbital—Hallucination—Temozolomide—skin cancer	0.000952	0.0119	CcSEcCtD
Secobarbital—Feeling abnormal—Imiquimod—skin cancer	0.000935	0.0117	CcSEcCtD
Secobarbital—CHRNA7—skin of body—skin cancer	0.000923	0.0358	CbGeAlD
Secobarbital—Body temperature increased—Imiquimod—skin cancer	0.000897	0.0112	CcSEcCtD
Secobarbital—CHRFAM7A—female reproductive system—skin cancer	0.000892	0.0346	CbGeAlD
Secobarbital—Dizziness—Vemurafenib—skin cancer	0.00088	0.011	CcSEcCtD
Secobarbital—Ataxia—Docetaxel—skin cancer	0.000865	0.0108	CcSEcCtD
Secobarbital—Vomiting—Vemurafenib—skin cancer	0.000846	0.0106	CcSEcCtD
Secobarbital—Rash—Vemurafenib—skin cancer	0.000839	0.0105	CcSEcCtD
Secobarbital—Dermatitis—Vemurafenib—skin cancer	0.000838	0.0105	CcSEcCtD
Secobarbital—Hypersensitivity—Imiquimod—skin cancer	0.000836	0.0104	CcSEcCtD
Secobarbital—Headache—Vemurafenib—skin cancer	0.000833	0.0104	CcSEcCtD
Secobarbital—GRIA2—head—skin cancer	0.000818	0.0317	CbGeAlD
Secobarbital—Confusional state—Bleomycin—skin cancer	0.000813	0.0102	CcSEcCtD
Secobarbital—GABRA6—head—skin cancer	0.000791	0.0307	CbGeAlD
Secobarbital—Nausea—Vemurafenib—skin cancer	0.00079	0.00987	CcSEcCtD
Secobarbital—GABRA5—head—skin cancer	0.000767	0.0297	CbGeAlD
Secobarbital—Agitation—Temozolomide—skin cancer	0.000766	0.00956	CcSEcCtD
Secobarbital—Angioedema—Temozolomide—skin cancer	0.000761	0.00951	CcSEcCtD
Secobarbital—CYP1A2—nipple—skin cancer	0.000756	0.0293	CbGeAlD
Secobarbital—Hypotension—Bleomycin—skin cancer	0.000753	0.00941	CcSEcCtD
Secobarbital—Dizziness—Imiquimod—skin cancer	0.00075	0.00937	CcSEcCtD
Secobarbital—CHRFAM7A—head—skin cancer	0.000746	0.0289	CbGeAlD
Secobarbital—GRIK2—head—skin cancer	0.000739	0.0287	CbGeAlD
Secobarbital—Vomiting—Imiquimod—skin cancer	0.000721	0.00901	CcSEcCtD
Secobarbital—CHRNA7—female reproductive system—skin cancer	0.000721	0.028	CbGeAlD
Secobarbital—Rash—Imiquimod—skin cancer	0.000715	0.00894	CcSEcCtD
Secobarbital—Dermatitis—Imiquimod—skin cancer	0.000715	0.00893	CcSEcCtD
Secobarbital—GABRA3—head—skin cancer	0.000714	0.0277	CbGeAlD
Secobarbital—Headache—Imiquimod—skin cancer	0.000711	0.00888	CcSEcCtD
Secobarbital—Anxiety—Temozolomide—skin cancer	0.000707	0.00883	CcSEcCtD
Secobarbital—GABRA4—head—skin cancer	0.000696	0.027	CbGeAlD
Secobarbital—Confusional state—Temozolomide—skin cancer	0.000686	0.00856	CcSEcCtD
Secobarbital—Nausea—Imiquimod—skin cancer	0.000674	0.00842	CcSEcCtD
Secobarbital—Feeling abnormal—Bleomycin—skin cancer	0.000664	0.0083	CcSEcCtD
Secobarbital—Body temperature increased—Bleomycin—skin cancer	0.000637	0.00796	CcSEcCtD
Secobarbital—Confusional state—Fluorouracil—skin cancer	0.000632	0.00789	CcSEcCtD
Secobarbital—Feeling abnormal—Dactinomycin—skin cancer	0.000619	0.00774	CcSEcCtD
Secobarbital—Somnolence—Temozolomide—skin cancer	0.000604	0.00755	CcSEcCtD
Secobarbital—CHRNA7—head—skin cancer	0.000602	0.0234	CbGeAlD
Secobarbital—Body temperature increased—Dactinomycin—skin cancer	0.000594	0.00742	CcSEcCtD
Secobarbital—CHRNA4—head—skin cancer	0.000594	0.023	CbGeAlD
Secobarbital—Hypersensitivity—Bleomycin—skin cancer	0.000594	0.00742	CcSEcCtD
Secobarbital—Hypotension—Fluorouracil—skin cancer	0.000585	0.00731	CcSEcCtD
Secobarbital—GABRG2—head—skin cancer	0.000582	0.0226	CbGeAlD
Secobarbital—GABRB2—head—skin cancer	0.000582	0.0226	CbGeAlD
Secobarbital—Constipation—Temozolomide—skin cancer	0.000581	0.00726	CcSEcCtD
Secobarbital—Feeling abnormal—Temozolomide—skin cancer	0.00056	0.007	CcSEcCtD
Secobarbital—Somnolence—Fluorouracil—skin cancer	0.000557	0.00696	CcSEcCtD
Secobarbital—Hypersensitivity—Dactinomycin—skin cancer	0.000554	0.00692	CcSEcCtD
Secobarbital—Body temperature increased—Temozolomide—skin cancer	0.000537	0.00671	CcSEcCtD
Secobarbital—GABRA2—head—skin cancer	0.000532	0.0206	CbGeAlD
Secobarbital—Feeling abnormal—Fluorouracil—skin cancer	0.000516	0.00645	CcSEcCtD
Secobarbital—GABRA1—head—skin cancer	0.000514	0.0199	CbGeAlD
Secobarbital—Vomiting—Bleomycin—skin cancer	0.000512	0.0064	CcSEcCtD
Secobarbital—Rash—Bleomycin—skin cancer	0.000508	0.00635	CcSEcCtD
Secobarbital—Dermatitis—Bleomycin—skin cancer	0.000508	0.00634	CcSEcCtD
Secobarbital—Hypersensitivity—Temozolomide—skin cancer	0.000501	0.00626	CcSEcCtD
Secobarbital—Syncope—Docetaxel—skin cancer	0.000497	0.00621	CcSEcCtD
Secobarbital—Body temperature increased—Fluorouracil—skin cancer	0.000495	0.00619	CcSEcCtD
Secobarbital—Loss of consciousness—Docetaxel—skin cancer	0.000487	0.00608	CcSEcCtD
Secobarbital—Nausea—Bleomycin—skin cancer	0.000479	0.00598	CcSEcCtD
Secobarbital—Vomiting—Dactinomycin—skin cancer	0.000478	0.00597	CcSEcCtD
Secobarbital—Rash—Dactinomycin—skin cancer	0.000474	0.00592	CcSEcCtD
Secobarbital—Hypersensitivity—Fluorouracil—skin cancer	0.000462	0.00577	CcSEcCtD
Secobarbital—Confusional state—Docetaxel—skin cancer	0.000456	0.0057	CcSEcCtD
Secobarbital—Dizziness—Temozolomide—skin cancer	0.00045	0.00562	CcSEcCtD
Secobarbital—Nausea—Dactinomycin—skin cancer	0.000447	0.00558	CcSEcCtD
Secobarbital—Shock—Docetaxel—skin cancer	0.000445	0.00556	CcSEcCtD
Secobarbital—Vomiting—Temozolomide—skin cancer	0.000432	0.0054	CcSEcCtD
Secobarbital—Rash—Temozolomide—skin cancer	0.000429	0.00536	CcSEcCtD
Secobarbital—Dermatitis—Temozolomide—skin cancer	0.000428	0.00535	CcSEcCtD
Secobarbital—Headache—Temozolomide—skin cancer	0.000426	0.00532	CcSEcCtD
Secobarbital—Hypotension—Docetaxel—skin cancer	0.000422	0.00528	CcSEcCtD
Secobarbital—Dizziness—Fluorouracil—skin cancer	0.000414	0.00517	CcSEcCtD
Secobarbital—CYP2C8—female reproductive system—skin cancer	0.000404	0.0157	CbGeAlD
Secobarbital—Nausea—Temozolomide—skin cancer	0.000404	0.00504	CcSEcCtD
Secobarbital—Somnolence—Docetaxel—skin cancer	0.000402	0.00502	CcSEcCtD
Secobarbital—Vomiting—Fluorouracil—skin cancer	0.000398	0.00498	CcSEcCtD
Secobarbital—Rash—Fluorouracil—skin cancer	0.000395	0.00493	CcSEcCtD
Secobarbital—Dermatitis—Fluorouracil—skin cancer	0.000395	0.00493	CcSEcCtD
Secobarbital—Headache—Fluorouracil—skin cancer	0.000392	0.0049	CcSEcCtD
Secobarbital—Constipation—Docetaxel—skin cancer	0.000387	0.00483	CcSEcCtD
Secobarbital—Feeling abnormal—Docetaxel—skin cancer	0.000373	0.00465	CcSEcCtD
Secobarbital—GABRA2—lymph node—skin cancer	0.000372	0.0144	CbGeAlD
Secobarbital—Nausea—Fluorouracil—skin cancer	0.000372	0.00465	CcSEcCtD
Secobarbital—CYP2C9—female reproductive system—skin cancer	0.000359	0.0139	CbGeAlD
Secobarbital—Body temperature increased—Docetaxel—skin cancer	0.000357	0.00446	CcSEcCtD
Secobarbital—Hypersensitivity—Docetaxel—skin cancer	0.000333	0.00416	CcSEcCtD
Secobarbital—Dizziness—Docetaxel—skin cancer	0.000299	0.00373	CcSEcCtD
Secobarbital—Vomiting—Docetaxel—skin cancer	0.000287	0.00359	CcSEcCtD
Secobarbital—Rash—Docetaxel—skin cancer	0.000285	0.00356	CcSEcCtD
Secobarbital—Dermatitis—Docetaxel—skin cancer	0.000285	0.00356	CcSEcCtD
Secobarbital—Headache—Docetaxel—skin cancer	0.000283	0.00354	CcSEcCtD
Secobarbital—Nausea—Docetaxel—skin cancer	0.000269	0.00335	CcSEcCtD
